BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18721523)

  • 21. Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy.
    Canepa M; Sorensen LL; Pozios I; Dimaano VL; Luo HC; Pinheiro AC; Strait JB; Brunelli C; Abraham MR; Ferrucci L; Abraham TP
    Am J Cardiol; 2013 Oct; 112(8):1182-9. PubMed ID: 24079444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography/European Association of Echocardiography.
    Barbieri A; Bursi F; Mantovani F; Valenti C; Quaglia M; Berti E; Marino M; Modena MG
    Eur Heart J Cardiovasc Imaging; 2012 Jan; 13(1):109-17. PubMed ID: 21979990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of various "classic" echocardiographic and laboratory indices in distinguishing the "gray zone" between athlete's heart and hypertrophic cardiomyopathy: a pilot study.
    Pagourelias ED; Efthimiadis GK; Kouidi E; Zorou P; Giannoglou G; Deligiannis A; Athyros VG; Karagiannis A; Geleris P
    Echocardiography; 2013 Feb; 30(2):131-9. PubMed ID: 23167844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of precordial voltages to left ventricular mass on echocardiogram in adolescent patients with hypertrophic cardiomyopathy compared with that in adolescent athletes.
    Guerrier K; Anderson JB; Pratt J; King EC; Statile C; Wilmot I; Campbell M; Czosek RJ
    Am J Cardiol; 2015 Apr; 115(7):956-61. PubMed ID: 25670640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States.
    Kitaoka H; Doi Y; Casey SA; Hitomi N; Furuno T; Maron BJ
    Am J Cardiol; 2003 Nov; 92(10):1183-6. PubMed ID: 14609593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography.
    Sun JP; Stewart WJ; Yang XS; Donnell RO; Leon AR; Felner JM; Thomas JD; Merlino JD
    Am J Cardiol; 2009 Feb; 103(3):411-5. PubMed ID: 19166699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular twist mechanics in hypertrophic cardiomyopathy assessed by three-dimensional speckle tracking echocardiography.
    Urbano Moral JA; Arias Godinez JA; Maron MS; Malik R; Eagan JE; Patel AR; Pandian NG
    Am J Cardiol; 2011 Dec; 108(12):1788-95. PubMed ID: 21924393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of real time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy: comparison with two-dimensional echocardiography and magnetic resonance imaging.
    Bicudo LS; Tsutsui JM; Shiozaki A; Rochitte CE; Arteaga E; Mady C; Ramires JA; Mathias W
    Echocardiography; 2008 Aug; 25(7):717-26. PubMed ID: 18445062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
    Maron MS; Zenovich AG; Casey SA; Link MS; Udelson JE; Aeppli DM; Maron BJ
    Am J Cardiol; 2005 Jun; 95(11):1329-33. PubMed ID: 15904638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
    Corona-Villalobos CP; Sorensen LL; Pozios I; Chu L; Eng J; Abraham MR; Abraham TP; Kamel IR; Zimmerman SL
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):945-54. PubMed ID: 26896038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of Real Time 3D Echocardiography for the Assessment of Left Ventricular Mass in Patients with Hypertrophic Cardiomyopathy: Comparison with Cardiac Magnetic Resonance.
    Avegliano GP; Costabel JP; Asch FM; Sciancalepore A; Kuschnir P; Huguet M; Tobon-Gomez C; Frangi AF; Ronderos R
    Echocardiography; 2016 Mar; 33(3):431-6. PubMed ID: 26525462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The natural history of left ventricular wall thickening in hypertrophic cardiomyopathy.
    Semsarian C; French J; Trent RJ; Richmond DR; Jeremy RW
    Aust N Z J Med; 1997 Feb; 27(1):51-8. PubMed ID: 9079254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance.
    Petersen SE; Selvanayagam JB; Francis JM; Myerson SG; Wiesmann F; Robson MD; Ostman-Smith I; Casadei B; Watkins H; Neubauer S
    J Cardiovasc Magn Reson; 2005; 7(3):551-8. PubMed ID: 15959967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outflow acceleration assessed by continuous-wave doppler echocardiography in left ventricular hypertrophy: an analysis of 103 consecutive cases.
    Faber L; Heemann A; Sürig M; Michalowski Z; Gleichmann U; Klempt HW
    Cardiology; 1998 Dec; 90(3):220-6. PubMed ID: 9892772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of left ventricular mass in hypertrophic cardiomyopathy by real-time three-dimensional echocardiography using single-beat capture image.
    Chang SA; Kim HK; Lee SC; Kim EY; Hahm SH; Kwon OM; Park SW; Choe YH; Oh JK
    J Am Soc Echocardiogr; 2013 Apr; 26(4):436-42. PubMed ID: 23363779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological quantification and differentiation of left ventricular hypertrophy in hypertrophic cardiomyopathy and hypertensive heart disease. A two dimensional echocardiographic study.
    Keller H; Wanger KC; Goepfrich M; Stegaru B; Buss J; Heene DL
    Eur Heart J; 1990 Jan; 11(1):65-74. PubMed ID: 2137778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Echocardiographic characteristics of PRKAG2 syndrome: a research using three-dimensional speckle tracking echocardiography compared with sarcomeric hypertrophic cardiomyopathy.
    Tang L; Li X; Zhou N; Jiang Y; Pan C; Shu X
    Cardiovasc Ultrasound; 2022 May; 20(1):14. PubMed ID: 35509080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between intraventricular myocardial systolic dyssynchrony and ventricular arrhythmias in patients with hypertrophic cardiomyopathy.
    D'Andrea A; Caso P; Severino S; Scotto di Uccio F; Vigorito F; Ascione L; Scherillo M; Calabrò R
    Echocardiography; 2005 Aug; 22(7):571-8. PubMed ID: 16060893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sports-specific adaptation of left ventricular muscle mass in athlete's heart. I. An echocardiographic study with combined isometric and dynamic exercise trained athletes (male and female rowers).
    Urhausen A; Monz T; Kindermann W
    Int J Sports Med; 1996 Nov; 17 Suppl 3():S145-51. PubMed ID: 9119535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between left atrial and left ventricular function in hypertrophic cardiomyopathy: a real-time 3-dimensional echocardiographic study.
    Shin MS; Fukuda S; Song JM; Tran H; Oryszak S; Thomas JD; Shiota T
    J Am Soc Echocardiogr; 2006 Jun; 19(6):796-801. PubMed ID: 16762759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.